The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine

  • Azadeh Zarei Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Mehrdad Karimi Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Hossein Rezaeizadeh Department of Traditional Persian Medicine, School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Heart Diseases, Liver Diseases, Heart Liver Axis, Network Medicine, Iranian Traditional Medicine


Background: Liver and Heart are two important organs in the human body, whose function strongly affects other organs. On the other hand, these two main organs affect each other due to common metabolic pathways. Therefore, a disorder in any of them can lead to disease in other organs. Today, using the network medicine perspective, these complex connections can be easily mapped and discovered. From the Persian medicine viewpoint, links are formed based on the material causes of diseases, while from the conventional medicine viewpoint, they are mostly formed due to metabolites, genes, and pathways. Materials and methods: In this article, we first investigated the recent articles of conventional medicine that examine the relationship between Heart and Liver in the important databases. Then we checked out the sources of Persian medicine and finally, using the RStudio software used in network medicine for text mining, we drew the communication network centered on Heart and liver and their mutual causes from the perspective of Persian Medicine. Results: Examining the network connection between the heart and the liver showed that the definitions based on Persian medicine, which are based on the material causes of diseases, are very compatible with the genes, metabolites and pathways between these two organs. Conclusion: understanding these concepts can be helpful in detecting the co-occurrence of diseases of these two organs, as well as predicting the possible occurrence of related diseases between the heart and liver, and ultimately in better treatment.[GMJ.2023;12:e2557]


Zeb I, Li D, Budoff MJ, Katz R, Lloyd-Jones D, Agatston A, et al. Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis. JACC . 2016;67(16):1965-6.


VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA, et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology. 2015;62(3):773-83.

PMid:25914296 PMCid:PMC4549239

Vita T, Murphy DJ, Osborne MT, Bajaj NS, Keraliya A, Jacob S, et al. Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET/CT. Radiology. 2019;291(2):330-7.

PMid:30835188 PMCid:PMC6492883

Ito M, Adachi-Akahane S. Inter-organ communication in the regulation of lipid metabolism: focusing on the network between Liver, intestine, and Heart. Journal of pharmacological sciences. 2013:13R09CP.


Ambale Venkatesh B, Lima JA. Probing Liver Heart Axis. Radiological Society of North America. 2019;291(2):338-9.


Baskin KK, Bookout AL, Olson EN. The Heart-liver metabolic axis: defective communication exacerbates disease. EMBO molecular medicine. 2014;6(4):436-8.

PMid:24623378 PMCid:PMC3992070

Avicenna (Ibn Sina). The canon of medicine. Beirut, Lebanon: Institute Dare Ehya al-Toras; 2005.

Azam Khan M. Exir Azam [Persian] Tehran,Iran: Institute of Meical History, Islamic Medicine and Complementary Medicine; 2008.

Zargaran A, Mehdizadeh A, Zarshenas MM, Mohagheghzadeh A. Avicenna (980-1037 AD). Journal of neurology. 2012;259(2):389-90.


Aghili Shirazi MH. Moalejat-e Aghili (Persian). Tehran: Institute of Meical History, Islamic Medicine and Complementary Medicine; 2008.

Chou E. Mastering Python Networking. Birmingham: Packt Publishing Ltd; 2017.

Kronthaler F, Zöllner S. Data Analysis with RStudio: Springer; 2021.

Shirbeigi L, Zarei A, Naghizadeh A, Vaghasloo MA. The concept of temperaments in traditional Persian medicine. Traditional and Integrative Medicine. 2017:143-56.

Zarei A, Noroozi S, Khadem E. A Review on the Structure and Function of Liver from Avicenna Point of View and Its Comparison with Conventional Medicine. Traditional and Integrative Medicine. 2019;18:28-36.

Zarei A, Rezaeizadeh H, Karimi M. Persian Medicine Perspective on the Network Between Liver and Other Organs. Hepatitis Monthly. 2021;21(11):e123088.

Rezadoost H, Karimi M, Jafari M. Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study. Scientific reports. 2016;6(1):1-8.

PMid:27452083 PMCid:PMC4959000

Jorjani E. zakhire kharazmshahi[in persian]. Tehran: Iranian Medical Academy; 2001.

Aghili M. Kholase al hekmah. Quom, Iran: Esmailian. 2006:35-42.

Kermani N-I-E. Sharh-al-Asbab V-al-Alamaat. Tehran: Tehran University of Medical Sciences; 2004.

Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic Heart failure: prevalence, characteristics and prognostic significance. European journal of clinical investigation. 2012;42(2):153-63.


Kazantzis M, Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2012;1821(5):852-7.

PMid:21979150 PMCid:PMC3274620

Vela D. Balance of cardiac and systemic hepcidin and its role in Heart physiology and pathology. Laboratory investigation. 2018;98(3):315-26.


Hernandez-Anzaldo S, Berry E, Brglez V, Leung D, Yun TJ, Lee JS, et al. Identification of a novel Heart-liver axis: matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate lipid metabolism and inflammation in Liver. Journal of the American Heart Association. 2015;4(11):e002553.

PMid:26567374 PMCid:PMC4845223

Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A, et al. Analysis of liver metabolism in a rat model of Heart failure. International journal of cardiology. 2012;161(3):130-6.


Tang T-T, Li Y-Y, Li J-J, Wang K, Han Y, Dong W-Y, et al. Liver-Heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction. Theranostics. 2018;8(16):4552.

PMid:30214638 PMCid:PMC6134935

Mantovani A. Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of Liver-Heart axis. Journal of clinical and translational hepatology. 2017;5(2):134.

PMid:28660151 PMCid:PMC5472934

Ambale Venkatesh B, Lima JA. Probing Liver Heart Axis. Radiological Society of North America. 2019;291(2): 338-9.


Mukhopadhyay R. Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation. Journal of applied genetics. 2013;54(2):185-92.


Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. Atherosclerosis. 2010;211(1):182-6.


Ostovaneh MR, Ambale-Venkatesh B, Fuji T, Bakhshi H, Shah R, Murthy VL, et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circulation: Cardiovascular Imaging. 2018;11(3):e007241.

PMid:29523555 PMCid:PMC5846116

de Bold AJ. Thirty years of research on atrial natriuretic factor: historical background and emerging concepts. Canadian journal of physiology and pharmacology. 2011;89(8):527-31.


Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in Heart failure and its relation to the severity of tricuspid regurgitation. American Journal of Cardiology. 2002;90(12):1405-9.


Vasconcelos LABA, Almeida EAd, Bachur LF. Clinical evaluation and hepatic laboratory assessment in individuals with congestive Heart failure. Arquivos brasileiros de cardiologia. 2007;88:590-5.


Correale M, Tarantino N, Petrucci R, Tricarico L, Laonigro I, Di Biase M, et al. Liver disease and Heart failure: Back and forth. European Journal of Internal Medicine. 2018;48:25-34.


Alvarez AM, Mukherjee D. Liver abnormalities in cardiac diseases and Heart failure. International Journal of Angiology. 2011;20(03):135-42.

PMid:22942628 PMCid:PMC3331650

Yamada T, Kotake Y, Nagata H, Takeda J. Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits. Journal of anesthesia. 2013;27(6):901-8.


Noghani MT, Namdar H. Migraine associated with gastrointestinal disorders: a pathophysiological explanation. Medical hypotheses. 2019;125:90-3.


Horvatits T, Drolz A, Rutter K, Roedl K, Kluge S, Fuhrmann V. Hepatocardiac disorders. World J Hepatol. 2014;6(1):41-54.

PMid:24653793 PMCid:PMC3953805

Nakamura M, Sadoshima J. Heart over mind: metabolic control of white adipose tissue and liver. EMBO Molecular Medicine. 2014;6(12):1521-4.

PMid:25471454 PMCid:PMC4287972

Ghaderi. Fosool-Ol-Aaraz. Tehran: Iran University of Medical Sciences; 2008.

Ibn-abbas A. Kamel-Al-sana-ah-Al-Tebbiah. Qom: Jalal-el-Din; 2008.

How to Cite
Zarei, A., Karimi, M., & Rezaeizadeh, H. (2023). The Network between Heart and Liver from the View of Persian Medicine Versus Conventional Medicine. Galen Medical Journal, 12, e2557.
Original Article